The Pan-Immune-Inflammation Value is a new prognostic biomarker in metastatic colorectal cancer: results from a pooled-analysis of the Valentino and TRIBE first-line trialsGiovanni Fucà, Filippo Pietrantonio, Lorenza Rimassa et al.|British Journal of Cancer|2020Cited by 350
Modulation of peripheral blood immune cells by early use of steroids and its association with clinical outcomes in patients with metastatic non-small cell lung cancer treated with immune checkpoint inhibitorsGiovanni Fucà, Diego Signorelli|ESMO Open|2019Cited by 209
Morcellation worsens survival outcomes in patients with undiagnosed uterine leiomyosarcomas: A retrospective MITO group studyFrancesco Raspagliesi, Domenica Lorusso, Giuseppa Maltese et al.|Gynecologic Oncology|2016Cited by 88
Impact of systemic and tumor lipid metabolism on everolimus efficacy in advanced pancreatic neuroendocrine tumors (pNETs)Claudio Vernieri, Filippo de Braud, Sara Pusceddu et al.|International Journal of Cancer|2018Cited by 65